Piramal Pharma Limited

NSEI:PPLPHARMA Rapporto sulle azioni

Cap. di mercato: ₹326.0b

Piramal Pharma Gestione

Gestione criteri di controllo 1/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOno data
Proprietà del CEOn/a
Durata media del managementNessun dato
Durata media del Consiglio di amministrazione3.8yrs

Aggiornamenti recenti sulla gestione

Recent updates

₹284 - That's What Analysts Think Piramal Pharma Limited (NSE:PPLPHARMA) Is Worth After These Results

Oct 26
₹284 - That's What Analysts Think Piramal Pharma Limited (NSE:PPLPHARMA) Is Worth After These Results

Piramal Pharma (NSE:PPLPHARMA) Takes On Some Risk With Its Use Of Debt

Oct 25
Piramal Pharma (NSE:PPLPHARMA) Takes On Some Risk With Its Use Of Debt

Here's Why Piramal Pharma (NSE:PPLPHARMA) Has A Meaningful Debt Burden

Jul 14
Here's Why Piramal Pharma (NSE:PPLPHARMA) Has A Meaningful Debt Burden

Estimating The Intrinsic Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Jun 17
Estimating The Intrinsic Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

We Think That There Are Issues Underlying Piramal Pharma's (NSE:PPLPHARMA) Earnings

May 21
We Think That There Are Issues Underlying Piramal Pharma's (NSE:PPLPHARMA) Earnings

It's A Story Of Risk Vs Reward With Piramal Pharma Limited (NSE:PPLPHARMA)

Mar 26
It's A Story Of Risk Vs Reward With Piramal Pharma Limited (NSE:PPLPHARMA)

Estimating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Feb 28
Estimating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Earnings Update: Here's Why Analysts Just Lifted Their Piramal Pharma Limited (NSE:PPLPHARMA) Price Target To ₹161

Feb 02
Earnings Update: Here's Why Analysts Just Lifted Their Piramal Pharma Limited (NSE:PPLPHARMA) Price Target To ₹161

Calculating The Intrinsic Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Nov 09
Calculating The Intrinsic Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Calculating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Aug 11
Calculating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

AMMINISTRATORE DELEGATO

Piramal Pharma non ha un CEO, o non abbiamo dati su di loro.

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Nandini Piramal
Executive Chairperson4.7yrs₹42.02m0.13%
₹ 430.3m
Vivek Valsaraj
President2.8yrs₹24.77mNessun dato
Peter DeYoung
CEO of Piramal Global Pharma & Director4.7yrs₹42.40m0.033%
₹ 106.2m
Neeraj Bharadwaj
Non-Executive Director4.1yrsNessun datoNessun dato
Subramanian Ramadorai
Independent Non-Executive Director3.8yrs₹4.35m0.0020%
₹ 6.6m
Sridhar Gorthi
Independent Non-Executive Director2.7yrs₹4.20mNessun dato
Vibha Rishi
Independent Non-Executive Director2.3yrs₹4.25mNessun dato
Peter Stevenson
Independent Non-Executive Additional Director2.7yrs₹3.80mNessun dato
Jairaj Purandare
Independent Non Executive Director3.8yrs₹4.55mNessun dato

3.8yrs

Durata media

58yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di PPLPHARMA sono considerati esperti (durata media dell'incarico 3.8 anni).